Pridopidine

DB11947InvestigationalSmall molecule

Pridopidine has been used in trials studying the treatment of Huntington's Disease.

Mechanism: Pharmacologically active on Dopamine receptor D2
Curator reviewed
Formula / weight: C₁₅H₂₃NO₂S · 281.41 g/mol (avg)
Code names: ACR16

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyYGKUEOZJFIXDGI-UHFFFAOYSA-NSMILESCCCN1CCC(CC1)C1=CC=CC(=C1)S(C)(=O)=O

Targets

What you can answer from here — as of September 20, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pridopidine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.